首页> 外文期刊>Vascular pharmacology >Vascular dilation by paeonol--a mechanism study.
【24h】

Vascular dilation by paeonol--a mechanism study.

机译:丹皮酚进行血管扩张的机理研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The goal of this study was to investigate the mechanism underlaying the vasodilatory effect of paeonol, a major active element from the root bark of Chinese herbs Paeonia suffruticosa Andr. and Cynanchum paniculatum (Bunge) Kitagawa. Paeonol relaxed isolated rat aorta rings by 95.6% while the 10(-6) M forskolin-induced vasodilatation used as 100%. The EC(50) of vasodilatation by paeonol is 2.9x10(-4) M. Although paeonol exerted endothelium-independent relaxation, L-NAME treatment inhibited paeonol-induced vasodilation of endothelium intact rings, while indomethacin did not. Both L-NAME and ODQ did not affect paeonol relaxation in the rings without endothelium. In addition, paeonol markedly elevated NO generation in cultured endothelial cells. Pre-treatment of propranolol, glibenclamide, TEA and BaCl(2) did not affect paeonol relaxation of endothelium removed rings. On the other hand, pre-treated of rings (without endothelium) with paeonol markedly blocked vasoconstriction induced by AngII, PGF(2alpha), 5-HT, dopamine, vasopressin, endothelin-1 and PE. The paeonol incubation also significantly attenuated KCl-induced contraction which mainly depended on Ca(2+) influx. In Ca(2+)-free medium (containing 10(-4) M of EGTA and 60 mM of KCl), paeonol suppressed the contraction curve of CaCl(2). In addition, paeonol also inhibited contraction by PE in Ca(2+) free solution (containing 10(-4) M of EGTA) which mainly relied on intracellular Ca(2+) release. Whole-cell patch-clamp experiment showed that paeonol shifted the I-V curve and the peak value of calcium currents was significantly inhibited. In conclusion, our study suggested that voltage-dependent and receptor-operated Ca(2+) channel, as well as intracellular Ca(2+) release were all inhibited by paeonol. An intracellular Ca(2+) regulatory mechanism may be responsible to potent vasodilatory effect of paeonol.
机译:这项研究的目的是研究影响丹皮酚的血管舒张作用的机制,丹皮酚是中草药Pa药Paeonia suffruticosa Andr根皮中的主要活性成分。以及北川的Cylanchum paniculatum(Bunge)。丹皮酚使离体大鼠主动脉环松弛了95.6%,而10(-6)M forskolin诱导的血管舒张作用则为100%。丹皮酚的血管舒张作用的EC(50)为2.9x10(-4)M。尽管丹皮酚具有内皮依赖性的舒张功能,但L-NAME处理抑制了丹皮酚诱导的内皮完整环的血管舒张作用,而消炎痛则没有。 L-NAME和ODQ均不影响无内皮环中的丹皮酚松弛。此外,丹皮酚显着提高了培养的内皮细胞中NO的生成。普萘洛尔,格列本脲,TEA和BaCl(2)的预处理不会影响丹皮酚对内皮细胞去除环的松弛作用。另一方面,用丹皮酚预处理的环(无内皮)可显着阻断AngII,PGF(2α),5-HT,多巴胺,血管加压素,内皮素-1和PE诱导的血管收缩。丹皮酚的孵育还显着减弱了KCl诱导的收缩,这主要取决于Ca(2+)的流入。在无Ca(2+)的介质(包含10(-4)M的EGTA和60 mM的KCl)中,丹皮酚抑制了CaCl(2)的收缩曲线。此外,丹皮酚还抑制PE在无Ca(2+)溶液(含EGTA的10(-4)M)中的收缩,该溶液主要依赖于细胞内Ca(2+)的释放。全细胞膜片钳实验显示丹皮酚改变了I-V曲线,钙电流的峰值被显着抑制。总之,我们的研究表明电压依赖性和受体操作的Ca(2+)通道以及细胞内Ca(2+)释放均受丹皮酚抑制。细胞内Ca(2+)调节机制可能负责丹皮酚的有效血管舒张作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号